Modulight Oyj · OMXHEX:MODU
Modulight Oyj — Q3 2026 Earnings Presentation
13 slides from Modulight Oyj's earnings presentation, Oct 26, 2026
Slide 1: Welcome to the 3Q26 webinar
Welcome to the 3Q26 webinar 26th October 2026
Slide 2: Today’s agenda
Today’s agenda ▪ This is Modulight ▪ Q3 in nutshell ▪ Financial highlights ▪ R&D pipeline progress ▪ Outlook ▪ Summary ▪ Q&A
Slide 3: We fight cancer with science and technology
We fight cancer with science and technology ▪ We are a life science company that designs and manufactures laser devices for the treatment of cancer and eye diseases ▪ We also manufacture products for other high- value applications such as flow cytometry, microscopy, semiconductor, quantum, and defen
Slide 4: Modulight
Ce modulight
Slide 5: Q3 in brief
Q3 in brief ▪ Revenue growing to EUR 1,886 (1,765) thousand ▪ Pipeline is progressing 37 (32) projects and customer base & product mix continues to diversify Order intake reached one ▪ Many customer projects progressed of the strongest levels in towards production the company’s history ▪ Increased a
Slide 6: Financial highlights Jul-Sep 2026
Financial highlights Jul-Sep 2026 ▪ PPT business continued to show very strong growth 110% ▪ Revenue 7% higher than in the Revenue EBITDA EBIT corresponding period of 2025, influenced also by PPT sales increase ▪ EBITDA 53% which is an improvement of 645% EUR EUR EUR ▪ Product platforms are being us
Slide 7: Financial highlights Jan-Sep 2026
Financial highlights Jan-Sep 2026 ▪ PPT business continued good progress in terms of number of indications and sites, 127% increase in 1Q-3Q26 vs 2025 ▪ Revenue 7% lower than in the Revenue EBITDA EBIT corresponding period of 2025 ▪ EBITDA 28% which is an improvement of 269% due to continuous focus
Slide 8: Key figures
Key figures Group EUR 1,000 unless otherwise noted 7–9/2026 7-9/2025 1–9/2026 1-9/2025 1–12/2025 1) Revenue 1,886 1,765 4,985 5,333 7,069 EBITDA 1,003 -184 1,370 -810 -168 EBITDA - % 53.2 % -10.5 % 27.5 % -15.2 % -2.4 % Operating result (EBIT) -393 -1,220 -2,802 -3,861 -4,648 Operating result (EBIT)
Slide 9: R&D pipeline progresses towards qualification & production
R&D pipeline progresses towards qualification & production ▪ R&D pipeline grew to 37 (32) projects and growth coming from very large Number of projects with commercialization potential companies – aim in all projects is to commercialize our own products 40 ▪ Several pipeline projects progressing tow
Slide 10: Modulight’s customer base
Modulight’s customer base Customer ownership Very large companies share 40 in customer portfolio 35 increases 30 ▪ 48% have over 1bn revenue 25 ▪ 68% of customers are listed companies 20 ▪ 70% are established 15 companies ▪ 27% are privately owned 10 ▪ 5% are research companies 5 0 3Q23 4Q23 1Q24 2Q
Slide 11: Outlook
Outlook The company expects to grow its revenues and EBITDA in the financial year 2026. The purpose of introducing guidance is to increase transparency and improve the predictability of the company’s financial development for investors and other stakeholders. The guidance reflects management’s curre
Slide 12: Summary
Summary ▪ Pipeline is increasing and share of large customers is now 48% (35%) ▪ EBITDA improved 645% from 3Q25, remaining positive and reaching 53% Q3 & Sales 7% YoY ▪ Increased activity among globally significant companies with efforts to accelerate the transition to production ▪ Cost savings & in
Slide 13: Thank you! Questions?
Thank you! Questions?